Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.

Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.

We examined the long-term effects of everolimus in patients with renal angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.Following favorable results from the double-blind core phase of EXIST-2 (NCT00790400), patients were allowed to receive open-label eve...

Full description

Bibliographic Details
Main Authors: John J Bissler, J Chris Kingswood, Elzbieta Radzikowska, Bernard A Zonnenberg, Elena Belousova, Michael D Frost, Matthias Sauter, Susanne Brakemeier, Petrus J de Vries, Noah Berkowitz, Maurizio Voi, Severine Peyrard, Klemens Budde
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5549893?pdf=render

Internet

http://europepmc.org/articles/PMC5549893?pdf=render

Similar Items